糖尿病性视网膜病变
医学
下调和上调
糖尿病
旁分泌信号
视网膜
基因敲除
炎症
胞外囊泡
细胞凋亡
内分泌学
内科学
视网膜
微泡
受体
视网膜病变
癌症研究
药理学
内皮功能障碍
细胞生物学
小RNA
链脲佐菌素
细胞
促炎细胞因子
外体
细胞外
内皮干细胞
细胞因子
神经血管束
作者
Meili Wu,Haoyuan Zhou,Tianyi Zong,Ziwen Li,Yujuan Cao,Qian Yang,Tong Mu,Tianhua Xie,Xiaolu Wang,Yong Yao
标识
DOI:10.1007/s11626-026-01205-8
摘要
Abstract Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness in industrialized countries, resulting from diabetes mellitus. Prostaglandin E 2 (PGE 2 ), synthesized by cyclooxygenases, contributes to inflammation and apoptosis via the E-prostanoid receptor 2 (EP 2 R). Our previous studies demonstrated that EP 2 R antagonists mitigate inflammation and microvascular dysfunction in streptozotocin (STZ)-induced DR. Given the paracrine role of extracellular vesicles (EVs) in DR, we hypothesized that EVs derived from human endothelial cells (ECs) may regulate the PGE 2 /EP 2 R pathway in DR. Using an STZ-induced diabetic mouse model, we administered intravitreal injections of AAV2-shEP 2 R and evaluated retinal histology, optical coherence tomography, and biochemical markers. EV morphology, size, and concentration from high glucose (HG)-treated ECs were analyzed. Small RNA expression in plasma EVs from DR patients was assessed via deep sequencing. EP 2 R inhibition via AAV2-mediated knockdown significantly reduced retinal vascular leakage, leukostasis, and retinal Müller cell (rMC) activation. MiRNA profiling revealed elevated levels of miR-423-5p and miR-21-5p in EVs from HG-treated ECs, which were suppressed in EVs from EP 2 R antagonist-treated cells. Notably, deep sequencing of plasma EVs from DR patients confirmed significant upregulation of these miRNAs compared to healthy controls. MiR-423-5p and miR-21-5p function as key paracrine mediators promoting Müller cell activation and retinal microvascular dysfunction in DR. These findings highlight the potential of circulating EVs as vehicles for miRNA-based therapeutic interventions in DR.
科研通智能强力驱动
Strongly Powered by AbleSci AI